Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
60
datasets available to search
ShareScore release 0.9.0
Dataset results
60 results for “exon skipping”
Post-translational regulation of the exon skipping machinery controls aberrant splicing in T cell leukemia [Jurkat_shSRSF6]
GEO Series GSE139621. Homo sapiens. 6 samples. Type: Expression profiling by high throughput sequencing.
Targeting a pathogenic cryptic exon that drives HLRCC to induce exon skipping
GEO Series GSE292376. Homo sapiens. 6 samples. Type: Other.
A Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 44 Skipping to Evaluate the Safety and Efficacy of ENTR-601-44
ClinicalTrials.gov study NCT07037862. IPD Sharing: NO. Countries: 4. Publications: 0.
Study of AOC 1044 in Healthy Adult Volunteers and Participants With Duchenne Muscular Dystrophy (DMD) Mutations Amenable to Exon 44 Skipping
ClinicalTrials.gov study NCT05670730. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Crizotinb or Standard Chemotherapy in Met Exon 14 Skipping Advanced NSCLC
ClinicalTrials.gov study NCT04322578. IPD Sharing: Not stated. Countries: 1. Publications: 0.
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
ClinicalTrials.gov study NCT03175224. IPD Sharing: NO. Countries: 11. Publications: 0.
A Phase II, Open-Label, Multicenter Study of Capmatinib in Subjects With MET Exon 14 Skipping Mutation Positive, Advanced, NSCLC With Brain Metastases
ClinicalTrials.gov study NCT04460729. IPD Sharing: YES. Countries: 0. Publications: 0.
Observational Study of Patients With Duchenne Muscular Dystrophy Theoretically Treatable With Exon 53 Skipping
ClinicalTrials.gov study NCT01385917. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Becker Muscular Dystrophy - A Natural History Study to Predict Efficacy of Exon Skipping
ClinicalTrials.gov study NCT01539772. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Real-World Assessment of Clinical Outcomes in Metastatic NSCLC Patients With MET Exon 14 Skipping Mutation and Brain Metastases Treated With Capmatinib
ClinicalTrials.gov study NCT05675683. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Duchenne Muscular Dystrophy Tissue Bank for Exon Skipping
ClinicalTrials.gov study NCT01772043. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
ClinicalTrials.gov study NCT06031688. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 45 Skipping to Evaluate the Safety and Efficacy of ENTR-601-45
ClinicalTrials.gov study NCT07038824. IPD Sharing: NO. Countries: 5. Publications: 0.
A Study Of PGN-EDO51 In Participants With Duchenne Muscular Dystrophy Amenable To Exon 51-Skipping Treatment
ClinicalTrials.gov study NCT06079736. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Treatment Patterns and Real-World Clinical Outcomes in Patients With Advanced NSCLC and MET Exon 14 Skipping Mutation in the United States
ClinicalTrials.gov study NCT06161051. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Two-Part Study for Dose Determination of Vesleteplirsen (SRP-5051) (Part A), Then Dose Expansion (Part B) in Participants With Duchenne Muscular Dystrophy Amenable to Exon 51-Skipping Treatment
ClinicalTrials.gov study NCT04004065. IPD Sharing: Not stated. Countries: 8. Publications: 0.
Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-251 in Participants With Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping
ClinicalTrials.gov study NCT05524883. IPD Sharing: NO. Countries: 9. Publications: 0.
Capmatinib Plus Trametinib for the Treatment of Metastatic Non-small Cell Lung Cancer With MET Exon 14 Skipping Mutation
ClinicalTrials.gov study NCT05435846. IPD Sharing: NO. Countries: 1. Publications: 0.
Post-translational regulation of the exon skipping machinery controls aberrant splicing in T cell leukemia [CUTLL1_H3B-8800]
GEO Series GSE139616. Homo sapiens. 6 samples. Type: Expression profiling by high throughput sequencing.
Exon skipping in genes encoding lineage-defining myogenic transcription factors in rhabdomyosarcoma
GEO Series GSE210475. Homo sapiens. 7 samples. Type: Expression profiling by high throughput sequencing.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.